These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25218918)

  • 1. Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations.
    Knudsen HK; Roman PM
    J Subst Abuse Treat; 2015 Feb; 49():1-7. PubMed ID: 25218918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Science-based and practice-based innovativeness and performance of substance abuse treatment facilities.
    Nayar P; Yu F; Apenteng B
    Health Care Manage Rev; 2014; 39(1):66-74. PubMed ID: 23358133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with the adoption of evidence-based innovations by substance use disorder treatment organizations: A study of HIV testing.
    Broffman L; D'Aunno T; Chang JE
    J Subst Abuse Treat; 2023 Jan; 144():108929. PubMed ID: 36402124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing evidence-based psychosocial treatment in specialty substance use disorder care.
    Manuel JK; Hagedorn HJ; Finney JW
    Psychol Addict Behav; 2011 Jun; 25(2):225-37. PubMed ID: 21668085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the relationship between staff perceptions of organizational readiness to change and the process of innovation adoption in substance misuse treatment programs.
    Kelly P; Hegarty J; Barry J; Dyer KR; Horgan A
    J Subst Abuse Treat; 2017 Sep; 80():6-25. PubMed ID: 28755775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying and ranking implicit leadership strategies to promote evidence-based practice implementation in addiction health services.
    Guerrero EG; Padwa H; Fenwick K; Harris LM; Aarons GA
    Implement Sci; 2016 May; 11():69. PubMed ID: 27180231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of treatment innovation planning and implementation: strategic process models and organizational challenges.
    Lehman WE; Simpson DD; Knight DK; Flynn PM
    Psychol Addict Behav; 2011 Jun; 25(2):252-61. PubMed ID: 21443294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Random or predictable?: Adoption patterns of chronic care management practices in physician organizations.
    Miake-Lye IM; Chuang E; Rodriguez HP; Kominski GF; Yano EM; Shortell SM
    Implement Sci; 2017 Aug; 12(1):106. PubMed ID: 28836996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State Adoption of Incentives to Promote Evidence-Based Practices in Behavioral Health Systems.
    Stewart RE; Marcus SC; Hadley TR; Hepburn BM; Mandell DS
    Psychiatr Serv; 2018 Jun; 69(6):685-688. PubMed ID: 29493412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Training in Implementation Practice Leadership (TRIPLE): evaluation of a novel practice change strategy in behavioral health organizations.
    Proctor E; Ramsey AT; Brown MT; Malone S; Hooley C; McKay V
    Implement Sci; 2019 Jun; 14(1):66. PubMed ID: 31221201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical transformation: Manager's perspectives on implementation of evidence-based practice.
    Fearing G; Barwick M; Kimber M
    Adm Policy Ment Health; 2014 Jul; 41(4):455-68. PubMed ID: 23494388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators.
    O'Malley DM; Abraham CM; Lee HS; Rubinstein EB; Howard J; Hudson SV; Kieber-Emmons AM; Crabtree BF
    Fam Pract; 2022 Mar; 39(2):282-291. PubMed ID: 34423366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health provider attitudes toward adoption of evidence-based practice: the Evidence-Based Practice Attitude Scale (EBPAS).
    Aarons GA
    Ment Health Serv Res; 2004 Jun; 6(2):61-74. PubMed ID: 15224451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing E-Health adoption readiness using diffusion of innovation theory and the role mediated by each adopter's category in a Mauritian context.
    Putteeraj M; Bhungee N; Somanah J; Moty N
    Int Health; 2022 May; 14(3):236-249. PubMed ID: 34114007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Change in the ARC Organizational Strategy: Increasing Mental Health Clinicians' EBP Adoption Through Improved Organizational Culture and Capacity.
    Williams NJ; Glisson C; Hemmelgarn A; Green P
    Adm Policy Ment Health; 2017 Mar; 44(2):269-283. PubMed ID: 27236457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking the elements of change: Program and client responses to innovation.
    Simpson DD; Joe GW; Rowan-Szal GA
    J Subst Abuse Treat; 2007 Sep; 33(2):201-9. PubMed ID: 17433862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the adoption of an innovation: an examination of the uptake of the Canadian Heart Health Kit (HHK).
    Scott SD; Plotnikoff RC; Karunamuni N; Bize R; Rodgers W
    Implement Sci; 2008 Oct; 3():41. PubMed ID: 18831766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adopting evidence-based medically assisted treatments in substance abuse treatment organizations: roles of leadership socialization and funding streams.
    Blum TC; Davis CD; Roman PM
    J Health Hum Serv Adm; 2014; 37(1):37-75. PubMed ID: 25004707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector.
    Abraham AJ; Roman PM
    J Stud Alcohol Drugs; 2010 May; 71(3):460-6. PubMed ID: 20409441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Climate for innovation, 12-step orientation, and tobacco cessation treatment.
    Muilenburg JL; Laschober TC; Eby LT
    J Subst Abuse Treat; 2014 Apr; 46(4):447-55. PubMed ID: 24355811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.